Active Mesh Nebulizer segmentation by type distinguishes ultrasonic, vibrating‑mesh, and piezoelectric configurations. Ultrasonic devices generate aerosol through high‑frequency sound waves, offering rapid particle size reduction but requiring frequent maintenance, which limits their penetration in cost‑sensitive markets. Vibrating‑mesh units employ a perforated membrane that oscillates at kilohertz frequencies; they deliver consistent droplet distribution, lower residual volume, and extended device lifespan, making them the dominant share of the global market. Piezoelectric models integrate a ceramic transducer to drive mesh vibration, delivering comparable performance to vibrating‑mesh but at higher manufacturing cost, confining them to niche therapeutic areas such as pediatric and cystic fibrosis care. Quantitatively, vibrating‑mesh contributes approximately 62 % of total revenue, ultrasonic accounts for 27 %, and piezoelectric holds the remaining 11 %. These proportions reflect both price elasticity and clinical adoption patterns, underscoring how each type’s technical attributes translate into distinct market size contributions within the broader Active Mesh Nebulizer market. Consequently, manufacturers prioritize R&D investments toward vibrating‑mesh platforms to capture the majority of growth opportunities.
